Molnupiravir: COVID drug linked to mutations that could 'spread the illness', scientists say
- A study has found that the antiviral drug molnupiravir can cause mutations in the COVID-19 virus, potentially leading to further infection and genetic diversity in the surviving viral population.
- These mutations were more likely in older age groups, which aligns with the use of antiviral treatment in higher-risk individuals.
- The findings of the study have raised questions about the overall benefits and risks of molnupiravir and similar drugs, urging regulators to consider the possibility of persistent antiviral-induced mutations when developing new treatments.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left6Leaning Right3Center14Last UpdatedBias Distribution61% Center
Bias Distribution
- 61% of the sources are Center
61% Center
L 26%
C 61%
13%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
